Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies

Wang, Yin, Liu, Yan, Malek, Sami N., Zheng, Pan, Liu, Yang·2011·Cell stem cell
DOI 10.1016/j.stem.2011.02.006

Cited by (410)

Items 301–400 of 410

  1. Networks of Transcription Factors for Oct4 Expression in Mice
    Yuqiang Li · 2017 · DNA and Cell Biology
  2. The stem cell zinc finger 1 (SZF1)/ZNF589 protein has a human-specific evolutionary nucleotide DNA change and acts as a regulator of cell viability in the hematopoietic system
    Letizia Venturini, Michael Stadler, Georgi Manukjan, Michaela Scherr, Brigitte Schlegelberger, Doris Steinemann, Arnold Ganser · 2015 · Experimental Hematology
  3. Development of small molecule inhibitors of hypoxia-inducible factors for cancer therapy
    Gregg L. Semenza · 2025 · Pharmacological Reviews
  4. Targeting HIF1α Peri-operatively Increased Post-surgery Survival in a Tongue Cancer Animal Model
    Soon‐Hyun Ahn, Joo Yeon Choi, Dong Wook Kim, Doh Young Lee, Eun-Hui Jeon, Woo‐Jin Jeong, Jin Ho Paik · 2015 · Annals of Surgical Oncology
  5. Wnt-Responsive Cancer Stem Cells Are Located Close to Distorted Blood Vessels and Not in Hypoxic Regions in a p53-Null Mouse Model of Human Breast Cancer
    Tegy John Vadakkan, John David Landua, Wen Bu, Wei Wei, Fuhai Li, Stephen T. C. Wong, Mary E. Dickinson, Jeffrey M. Rosen, Michael T. Lewis, Mei Zhang · 2014 · Stem Cells Translational Medicine
  6. Prolyl hydroxylase-2 inhibits liver tumor cell proliferation and cyclin D1 expression in a hydroxylase-dependent manner
    Yifeng Tao, Lin Feng, Ruidong Li, Jie Shen, Zheng-Xin Wang · 2016 · The International Journal of Biochemistry & Cell Biology
  7. Assessment of Stabilization and Activity of the HIFs Important for Hypoxia-Induced Signalling in Cancer Cells
    David Kung‐Chun Chiu, Misty Shuo Zhang, Aki Pui‐Wah Tse, Carmen Chak‐Lui Wong · 2019 · Methods in molecular biology
  8. Targeting Myelogenous Leukemia Stem Cells: Role of the Circulation
    Jane L. Liesveld · 2012 · Frontiers in Oncology
  9. HIF-α factors as potential therapeutic targets in leukemia
    Daniela Magliulo, Rosa Bernardi · 2018 · Expert Opinion on Therapeutic Targets
  10. Heterogeneity of Functional Properties of Clone 66 Murine Breast Cancer Cells Expressing Various Stem Cell Phenotypes
    Partha Mukhopadhyay, Tracy L. Farrell, Gayatri Sharma, Timothy R. McGuire, Barbara Jean O'Kane, John Graham Sharp · 2013 · PLoS ONE
  11. Benzimidazole analogs as potent hypoxia inducible factor inhibitors: synthesis, biological evaluation, and profiling drug-like properties.
    Jianjun Chen, Jin Wang, Luciana P. Schwab, Kyung‐Tae Park, Tiffany Nicole Seagroves, Lisa K. Jennings, Duane D. Miller, Wěi Li · 2014 · PubMed
  12. The hypoxia signaling pathway in the development of acute myeloid leukemia
    Liqing Yang, Yuanzhong Chen, Yong Wu · 2025 · Biomedicine & Pharmacotherapy
  13. ATP-Binding Cassette Subfamily G Member 2 in Acute Myeloid Leukemia: A New Molecular Target?
    Daniela Damiani, Mario Tiribelli · 2024 · Biomedicines
  14. Hypoxia Up-regulates HIF Expression While Suppressing Cell Growth and NOTCH Activity in Leukaemia Cells
    Mai Itoh, Yuki Okuhashi, Yusuke Takahashi, YURI SONODA, Salwa A. Mohammad, TATSUYA SAITO, Erika Shiratori, Shuji Tohda · 2019 · Anticancer Research
  15. Modulating redox homeostasis and cellular reprogramming through inhibited methylenetetrahydrofolate dehydrogenase 2 enzymatic activities in lung cancer
    Chun-Hao Chan, Chia-Yu Wu, Navneet Kumar Dubey, Hong-Jian Wei, Jui-Hua Lu, Samantha Mao, Joy N. Liang, Yu-Hsuan Liang, Hsin-Chung Cheng, Win‐Ping Deng · 2020 · Aging
  16. BCAT1 contributes to the development of TKI-resistant CML
    Yu Jiang, Difan Zhang, Xiaoxiao He, Chiqi Chen, Li Xie, Ligen Liu, Zhuo Yu, Ya‐Ping Zhang, Junke Zheng, Dan Huang · 2024 · Cellular Oncology
  17. The role of hypoxia-inducible factors in leukemias
    Donata Szymczak, Jarosław Dybko, Kazimierz Kuliczkowski · 2018 · Advances in Clinical and Experimental Medicine
  18. Leukemia Stem Cells in Chronic Myeloid Leukemia
    Yi Shan, Ngoc Ho DeSouza, Qiang Qiu, Shaoguang Li · 2019 · Advances in experimental medicine and biology
  19. Hypoxia and Hematopoiesis
    Paige Dausinas, Christopher Basile, Chase Junge, Melissa L. Hartman, Heather A. O’Leary · 2022 · Current Stem Cell Reports
  20. Targeting HIF function: the debate continues
    Paresh Vyas · 2014 · Blood
  21. Expression and Activity of Matrix Metalloproteinases in Leukemia.
    Ali Amin Asnafi, Marziye Bagheri, K. Zibara, Masumeh Maleki Behzad, S. Shahrabi · 2019 · Journal of pediatric hematology/oncology
  22. Tumor microenvironment as a novel therapeutic target for lymphoid leukemias
    Shahrzad Mousavi, Soheil Nouri, Arezoo Sadeghipour, Amir Atashi · 2025 · Annals of Hematology
  23. Alcohol-driven metabolic reprogramming promotes development of RORγt-deficient thymic lymphoma
    Rui Sun, Chao Lei, Liang Chen, Liqing He, Haixun Guo, Xiang Zhang, Wenke Feng, Jun Yan, Craig James McClain, Zhongbin Deng · 2022 · Oncogene
  24. Oncoproteomics: insight into current proteomic technologies in cancer biomarker discovery and treatment
    Shrestha Dutta, Swatilekha Ghosh, Abhishek B. Mishra, Rajgourab Ghosh · 2022 · Journal of Proteins and Proteomics
  25. Scouting for common genes in the heterogenous hypoxic tumor microenvironment and their validation in glioblastoma
    Ashish Bhushan, Ranbala Kumari, Tapasya Srivastava · 2021 · 3 Biotech
  26. Concise Review: Exploiting Unique Biological Features of Leukemia Stem Cells for Therapeutic Benefit
    Haojian Zhang, Shaoguang Li · 2019 · Stem Cells Translational Medicine
  27. Tissue “Hypoxia” and the Maintenance of Leukemia Stem Cells
    Persio Dello Sbarba, Giulia Cheloni · 2019 · Advances in experimental medicine and biology
  28. Pharmacological or genetic inhibition of hypoxia signaling attenuates oncogenic RAS-induced cancer phenotypes
    Jun‐yi Zhu, Xiaohu Huang, Yulong Fu, Yin Wang, Pan Zheng, Yang Liu, Zhe Han · 2021 · Disease Models & Mechanisms
  29. Genetic and pharmaceutical targeting of HIF1α allows combo-immunotherapy to boost graft vs. leukemia without exacerbation graft vs. host disease
    Christopher M. Bailey, Yuanyi Wei, Jinsong Yan, Dan Yang Huang, Peng Zhang, Chong Qi, Christopher A. Lazarski, Juanjuan Su, Fei Tang, Chun-Shu Wong et al. · 2023 · Cell Reports Medicine
  30. HIF-2α inhibition disrupts leukemia stem cell metabolism and impairs vascular microenvironment to enhance chronic myeloid leukemia treatment
    Jian Wang, Weiwei Ma, Junbin Huang, Guo Qiu, Tian Zhang, Qinghua Wei, Chong He, Dun‐hua Zhou, Meng Liang Zhao, Chun Chen et al. · 2024 · Cancer Letters
  31. A double blinded, placebo-controlled pilot study to examine reduction of CD34+/CD117+/CD133+ lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma
    Daisuke Ito, Michael O. Childress, Nicola J. Mason et al. · 2017 · F1000Research
  32. The manipulator behind “Scissors”: γ -secretase and its modulators in Alzheimer’s disease
    Gao Ning, Xing Fan, Juan Du, Zhao wenxue, Wang Sijia, Chen Meinei, Dong Xiaolong, Qi Yiming · 2025 · Frontiers in Aging Neuroscience
  33. Molecular Insight into Iron Homeostasis of Acute Myeloid Leukemia Blasts
    Emmanuel Pourcelot, Ghina El Samra, Pascal Mossuz, Jean‐Marc Moulis · 2023 · International Journal of Molecular Sciences
  34. A double blinded, placebo-controlled pilot study to examine reduction of CD34+/CD117+/CD133+ lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma
    Daisuke Ito, Michael O. Childress, Nicola J. Mason et al. · 2015 · F1000Research
  35. Venetoclax Combined with Intensive Chemotherapy: A New Hope for Refractory and/or Relapsed Acute Myeloid Leukemia?
    Ramy Rahmé, Thorsten Braun · 2024 · Journal of Clinical Medicine
  36. Leukemic stem cells as drivers of therapeutic resistance in acute myeloid leukemia
    Suellen L. R. Silva, Gabriela A. da C. Barbosa, João V.B. Rios, Daniel Pereira Bezerra · 2026 · Biomedicine & Pharmacotherapy
  37. Three-Dimensional In Vitro Models in Glioma Research - Focus on Spheroids
    Stine Skov, Charlotte Aaberg-Jessen, Ida Pind Jakobsen, Simon Kjr, Sren Kabell, Bjarne Winther · 2011 · InTech eBooks
  38. Survival impact of hypoxia-inducible factor-1 alpha (HIF-1α) in Nucleophosmin1 mutated acute myeloid leukemia
    Chantiya Chanswangphuwana, Narittee Sukswai, Nichthida Tangnuntachai, Ponlapat Rojnuckarin · 2024 · Annals of Hematology
  39. The critical role of DNA damage‐inducible transcript 4 ( DDIT4 ) in stemness character of leukemia cells and leukemia initiation
    Yishuang Li, Zhijie Cao, Haiyan Xing, Zhenya Xue, Wenbing Liu, Jiayuan Chen, Yihan Mei, Runxia Gu, Hui Wei, Shaowei Qiu et al. · 2025 · Molecular Oncology
  40. High Doses of Vitamin C and Leukemia: In Vitro Update
    Domenico Mastrangelo, Lauretta Massai, Giuseppe Fioritoni, Francesco Lo‐Coco, Nélida I. Noguera, Ugo Testa · 2018 · InTech eBooks
  41. Fructose Metabolism and Acute Myeloid Leukemia
    Rina Kansal · 2021 · Exploratory Research and Hypothesis in Medicine
  42. Effect of FLT3 ligand on the gene expression of TIM-3, HIF1-α, and TNF-α in an acute myeloid leukemia cell line
    Fatemeh Heidari, Nazanin Atieh Kazemi-Sefat, Parisa Feizollahi, Sajjad Gerdabi, Ali Akbar Pourfathollah, Masoumeh Ebtekar · 2025 · Molecular Biology Reports
  43. MYO9B deficiency promoted head and neck tumor progression through HIF1α/MYC/STAT2 signaling pathway
    Simin Gao, Xia Gao, Ning Wang · 2025 · Biochimica et Biophysica Acta (BBA) - General Subjects
  44. FLT3-ITD promotes immune checkpoint CD80 via ROS elevation in acute myeloid leukemia
    Libo Yan, Weimin Zhang, Qiyan Mo, Daogang Wang, Ning Xu, Mengzhe Yang, Tao Ren · 2025 · Frontiers in Immunology
  45. FBP1/HIF-1α Axis mediates macrophage metabolic reprogramming and serves as diagnostic biomarkers in atherosclerosis
    Min Li, Xinxin Liu, Xiaochen Yu · 2025 · International Immunopharmacology
  46. Next-generation CAR-T and CAR-NK cell therapies in hematologic malignancies: engineering for persistence, specificity, and safety
    Mutaz Jamal Al‐Khreisat, Waleed K. Abdulsahib, Ihsan Khudhair Jasim, H. Malathi, Priya Priyadarshini Nayak, D. Alex Anand, Gunjan Mukherjee, Aashna Sinha, Norbek Kholboyev · 2026 · Discover Oncology
  47. Hypoxia‐Inducible Factors as Guardians of Cancer Stem Cell Fate: Implications for Novel Therapies
    Qamar Abuhassan, Hamzeh J. Al‐Ameer, Hani Moslem Ahmed, Jasur Alimdjanovich Rizaev, Azizbek Togaev, Rasim Mahdi Salih, Mohaned Adil · 2026 · IUBMB Life
  48. Hypoxia and Regulation of Cancer Cell Stemness
    Suman Kumar Ray, Sukhes Mukherjee · 2025 · Springer eBooks
  49. Cancer Stem Cells: Biology and Potential Therapeutic Applications
    Monica Mangoni, Mariangela Sottili, Mauro Loi, Chiara Gerini, Icro Meattini, Lorenzo Livi · 2014 · Springer eBooks
  50. Echinomycin did not affect the safety of fracture healing: an experimental pilot study on a murine femur fracture model
    Thorsten Jentzsch, Stefan Michael Zimmermann, Flora Nicholls · 2016 · Patient Safety in Surgery
  51. Chronic Myeloid Leukaemia
    Débora A. Casolari, Junia V. Melo · 2015 · Springer eBooks
  52. Repurposing of Acriflavine to Target Chronic Myeloid Leukemia Treatment
    Rawan Nehme · 2021 · Current Medicinal Chemistry
  53. Effect of hypoxia on HIF-1α and NOS3 expressions in CD34+ cells of JAK2V617F-positive myeloproliferative neoplasms
    Can Veysel Şoroğlu, İldeniz Uslu-Bıçak, Selin Fulya Toprak, Akif Selim Yavuz, Selçuk Sözer · 2023 · Advances in Medical Sciences
  54. Hematopoietic Progenitor and Stem Cell Regulation during Development: Hypoxia and Niches
    Parisa Imanirad · 2013 · RePub (Erasmus University Rotterdam)
  55. Treatment of Graft-versus-Host Disease by Echinomycin in a New Humanized Mouse Model
    Yan Liu, Christopher M. Bailey, Christopher A. Lazarski, Chun-Shu Wong, Pan Zheng, Yang Liu, Yin Wang · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  56. From hypoxia single‐cell gene signatures to HIF targeting of AML leukemic stem cells
    Thomas Mercher, Juerg Schwaller · 2024 · HemaSphere
  57. A double blinded, placebo-controlled pilot study to examine reduction of CD34+/CD117+/CD133+ lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma
    Daisuke Ito, Michael O. Childress, Nicola J. Mason et al. · 2017 · F1000Research
  58. Natural extract–derived compounds for the treatment of hematological diseases through modulation of the bone marrow microenvironment
    Ningrui Wang, Ningning Zhu, Nana Zhou, Nanxi Dong, Jingjing Xiang, Baodong Ye, Jingjing Liu · 2026 · Frontiers in Chemistry
  59. The Molecular Mechanisms for Maintenance of Cancer Stem Cells in Chronic Myeloid Leukemia: A Dissertation
    Haojian Zhang · 2012 · The Journal of the American Medical Association (JAMA) Network (American Medical Association)
  60. Targeting metabolism: A potential strategy for hematological cancer therapy
    Xue Tang, Fen Chen, Li-Chun Xie, Sixi Liu, Huirong Mai · 2022 · World Journal of Clinical Cases
  61. Inhibition of the non homologous end joining process in the context of hypoxic tumor cells
    Bernard Salles · 2013 · HAL
  62. Breast Cancer Stem Cells: From Theory to Therapy
    Sarah J. Conley, Max S. Wicha · 2013 · Springer eBooks
  63. Identification and Biology of CML Stem Cells
    Hiromi Iwasaki, Koichi Akashi · 2015 · Springer eBooks
  64. Molecular Biology of Leukemias
    L. Medeiros, Sergej N. Konoplev · 2017 · Springer eBooks
  65. Additional Prognostic Markers of Human Colon Adenocarcinoma
    Margarita A. Bystriakova, S. A. Koshkin, А. V. Gavrilyukov · 2019 · Cell and Tissue Biology
  66. Nanotechnology advances in ovarian cancer
    Kiranmayi Patnala, Rama Rao Malla, Soumya Vishwas · 2021 · Elsevier eBooks
  67. HIF-опосредованные механизмы взаимосвязи устойчивости к гипоксии и опухолевого роста
    Dzhuliia Sh. Dzhalilova, Olga V. Makarova · 2021 · Biochemistry (Moscow)
  68. Novel strategies to overcome drug resistance in liver cancer
    Yin Wang · 2018 · Figshare
  69. Cancer stem cells
    Sara E. Ali, Dominique A. Bonnet · 2019
  70. A comprehensive single-cell expression atlas of human AML leukemia-initiating cells unravels the contribution of HIF pathway and its therapeutic potential
    Talía Velasco-Hernández, Juan L. Trincado, Meritxell Vinyoles, Adrià Closa, Francisco Gutiérrez‐Agüera, Òscar Molina, Virginia Rodríguez-Cortez, Paolo Petazzi, Sergi Beneyto‐Calabuig, Lars Velten et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  71. Redox signaling regulates breast cancer metastasis via HIF1α-stimulated EMT dynamics and metabolic reprogramming
    Zuen Ren, Malindrie Dharmaratne, Huizhi Liang, Outhiriaradjou Benard, Miriam Morales-Gallego, Kimita Suyama, Atefeh Taherian Fard, Jessica C. Mar, Michael B. Prystowsky, Larry Norton et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  72. Hypoxia: A Formidable Saboteur of the Anti-tumor Response
    Meriem Hasmim, Yosra Messai, Stéphane Terry, Bassam Janji, Muhammad Zaeem Noman, Salem Chouaı̈b · 2015 · Resistance to targeted anti-cancer therapeutics
  73. The role of prolyl hydroxylases in the function of leukaemic stem cells and the development of leukaemia
    Gillian Smith · 2015 · Enlighten: Theses (The University of Glasgow)
  74. An investigation into the role of chemokines in haemopoietic stem cell quiescence
    Amy Sinclair · 2015 · Enlighten: Theses (The University of Glasgow)
  75. Leukemic Stem Cells and Therapy Resistance
    T.C. Kubbenga · 2011 · Utrecht University Repository (Utrecht University)
  76. THE HYPOXIC HEMATOPOIETIC STEM CELL NICHE Consequences of Hypoxia-induced Transcription on Stem Cell Fate
    Matilda Rehn · 2011 · Lund University Publications (Lund University)
  77. Reply to Nugue and Wion: Targeting cancer stem cells’ hypoxic core
    Sarah J. Conley, Max S. Wicha · 2012 · Proceedings of the National Academy of Sciences
  78. Cancer Stem Cells: The Gist of the Matter
    Torben Redmer, Dirk Schumacher, Wasco Wruck · 2013 · Stem cell biology and regenerative medicine
  79. Mesenchymal Stem Cells: Pivotal Players in Hematopoietic Stem Cell
    Jérôme Larghero, Annelise Bennaceur Griscelli, Ali G. Turhan · 2014
  80. Targeting Key Stemness-Related Pathways in Human Cancers
    Krysta Mila Coyle, Margaret Lois Thomas, Mohammad Sultan, Paola Marcato · 2015 · Springer eBooks
  81. Metabolic Reprogramming and Hyaluronan Production in Cancer Stem Cells
    Tomomi Izumikawa, Naoki Itano · 2018 · Trends in Glycoscience and Glycotechnology
  82. АНАЛИЗ ДОПОЛНИТЕЛЬНЫХ ПРОГНОСТИЧЕСКИХ МАРКЕРОВ АДЕНОКАРЦИНОМЫ ТОЛСТОЙ КИШКИ ЧЕЛОВЕКА, "Цитология"
    Margarita A. Bystriakova, С. Л. Кошкин, Л. В. Гаврилюков · 2018 · Tsitologiya
  83. Análise comparativa de diferentes sistemas de cultivo tridimensionais para estabelecimento de um modelo in vitro de câncer de bexiga para ensaios de eficácia terapêutica
    Robson Luis Ferraz do Amaral · 2020 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  84. Targeting Leukemia Stem Cells
    Duane C. Hassane, Mónica L. Guzmán · 2014 · Springer eBooks
  85. Relationship between leukaemic stem cells and hematopoietic stem cells and their clinical application
    Samuel Sherng Young Wang · 2022 · Leukemia & lymphoma/Leukemia and lymphoma
  86. Treatment of Acute Myeloid Leukemia: A Concise Overview
    2020 · Abasyn Journal Life Sciences
  87. Leukemias
    Lia Ginaldi, Massimo De Martinis · 2012 · Humana Press eBooks
  88. Splicing role of PRPF40A/B paralogs in human myeloid cells
    Cheryl Weiqi Tan · 2021
  89. Metabolic Reprogramming and Hyaluronan Production in Cancer Stem Cells
    Tomomi Izumikawa, Naoki Itano · 2018 · Trends in Glycoscience and Glycotechnology
  90. Glutamine synthetase : a potential therapeutic target in acute myeloid leukemia
    Johanna Kreitz · 2022
  91. The MLL3/TP53/PIK3CA cancer driver mutations promote HIF1α-dependent recruitment and differentiation of pro-tumor ICOS hi GITR hi Blimp-1 + effector regulatory T cells in breast tumors
    Marie Boutet, Kenta Nishitani, Piril Erler, Nicole Couturier, Zheng Zhang, Anna Maria Militello, Marcelo Coutinho de Miranda, Emeline Barbieux, Erik Guillen, Masako Suzuki et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  92. Bioinformatics Analysis Identifies EPAS1 as a Novel Prognostic Marker Correlated with Immune Infiltration in Acute Myeloid Leukemia
    Shichun Wang, Pengyu Zhang · 2023 · Disease Markers
  93. Study of Hypoxic Bone Marrow Microenvironment Associated with Acute Myeloid Leukemia
    爱博 王 · 2023 · Advances in Clinical Medicine
  94. Cancer stem cells
    Sara E. Ali, Dominique A. Bonnet · 2024
  95. Modeling Human Bone Marrow Endosteal Niches Using Induced Pluripotent Stem Cells in Xeno-Free Conditions
    Qing Li, Marina Tsvetomilova Nikolova, Gangyu Zhang, Igor Červenka, Dominik Bürri, Evelia Plantier, Andrea Mazzoleni, Anaïs Lamouline, Barbara Treutlein, Iván Martín et al. · 2025 · SSRN Electronic Journal
  96. From Microbes to Medicine: Bacteriotherapy's Emerging Role in Cancer Treatment Strategies
    Anjana Goel, Istuti Saraswat, Ayushi Sharma, Jaikishan Chaudhary · 2025 · Current Cancer Therapy Reviews
  97. Stem Cells and Leukemia
    Vincenzo Giambra, Christopher R. Jenkins · 2011 · Springer eBooks
  98. Additional file 1 of The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin
    Gong Peng, Wang, Yin, Ge, Pengfei, Bailey, Christopher, Zhang, Peng, Zhang, Di, Meng, Zhaoli, Qi, Chong, Qian Chen, Chen, Jingtao et al. · 2021 · Figshare
  99. Influence of hypoxia on tumour cell susceptibility to cytotoxic T lymphocyte mediated lysis
    Muhammad Zaeem Noman · 2012 · theses.fr (ABES)
  100. Influence de la Transition Epithélio-Mésenchymateuse sur la réponse T cytotoxique anti-tumorale
    Intissar Akalay · 2013 · theses.fr (ABES)